Company Filing History:
Years Active: 2024-2025
Title: Cristina Bartella: Innovator in Peptide Research
Introduction
Cristina Bartella is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of peptide research, particularly in developing innovative solutions for various skin conditions. With two patents to her name, her work focuses on the intersection of neuroscience and dermatology.
Latest Patents
Cristina Bartella's latest patents include groundbreaking inventions aimed at improving skin health. The first patent involves peptides designed to inhibit cholinergic calcitonin gene-related peptide (CGRP) and acetylcholine (ACH) release. This invention addresses neuronal exocytosis and offers potential applications in pharmaceutical and cosmetic products for treating skin conditions such as wrinkles, excessive perspiration, and dermatitis. The second patent focuses on peptides that inhibit the muscarinic receptor M3 activity. These peptides are intended for use in products that alleviate skin issues related to inflammation, excessive sebum production, and other conditions mediated by muscarinic receptor activity.
Career Highlights
Cristina Bartella is affiliated with Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a., where she continues to advance her research in peptide applications. Her innovative work has positioned her as a key figure in the development of therapeutic solutions for skin disorders.
Collaborations
Cristina collaborates with talented professionals in her field, including Francesca Mancini and Isabel Devesa Giner. These partnerships enhance her research efforts and contribute to the advancement of peptide technology.
Conclusion
Cristina Bartella's contributions to peptide research are paving the way for new treatments in dermatology. Her innovative patents reflect her commitment to improving skin health through scientific advancements.